Compound 102
Identifiers
- Canonical SMILES:
CC(C)[C@H](NC(=O)[C@H](C)N)C(=O)N1CCC[C@H]1C(=O)NCC1CC1
- IUPAC name:
(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(cyclopropylmethyl)pyrrolidine-2-carboxamide
- InChi:
InChI=1S/C17H30N4O3/c1-10(2)14(20-15(22)11(3)18)17(24)21-8-4-5-13(21)16(23)19-9-12-6-7-12/h10-14H,4-9,18H2,1-3H3,(H,19,23)(H,20,22)/t11-,13-,14-/m0/s1
- InChiKey:
AVVAGMSMAIELCX-UBHSHLNASA-N
External links
11151918 |
CHEMBL360545 |
9327026 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 5.36 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 338.23 g/mol | |||
HBA | 7 | |||
HBD | 4 | |||
HBA + HBD | 11 | |||
AlogP | -0.29 | |||
TPSA | 104.53 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.9167 | Cyclo(prolylglycyl) | DB04541 | |
0.8776 | acetylleucyl-leucyl-norleucinal | DB07558 | |
0.7667 | Rapastinel | DB11801 | |
0.7667 | Dusquetide | DB11879 | |
0.7551 | Pramiracetam | DB13247 | |
0.7541 | Larazotide | DB05645 | |
0.7500 | Brivaracetam | DB05541 | |
0.7377 | Verpacamide A | DB04433 | |
0.7258 | NNZ-2591 | DB15601 | |
0.7143 | Valrocemide | DB06657 | |
0.6984 | Sinapultide | DB11332 | |
0.6970 | Glypromate | DB05633 | |
0.6970 | Trofinetide | DB06045 | |
0.6939 | Etiracetam | DB11868 | |
0.6939 | Levetiracetam | DB01202 |